---
title: "The ETF market is \"uneven,\" with Hong Kong stock-themed ETFs favored"
description: "Since the beginning of this year, the ETF market has shown a pattern of \"uneven heat.\" Despite net outflows from broad-based ETFs, Hong Kong stock-themed ETFs such as the Hang Seng TECH ETF, HK Connec"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/276800653.md"
published_at: "2026-02-24T23:21:08.000Z"
---

# The ETF market is "uneven," with Hong Kong stock-themed ETFs favored

> Since the beginning of this year, the ETF market has shown a pattern of "uneven heat." Despite net outflows from broad-based ETFs, Hong Kong stock-themed ETFs such as the Hang Seng TECH ETF, HK Connect Internet ETF, and HK Connect Innovative Drug ETF have seen net inflows, indicating the market's preference for Hong Kong stock assets and reflecting the current structural allocation logic in the market

Since the beginning of this year, the ETF market has shown an overall pattern of "uneven heat." Against the backdrop of net outflows from broad-based ETFs, Hong Kong stock thematic ETFs have broken through against the trend, becoming an important direction for capital allocation. Subcategories such as the Hang Seng TECH ETF, HK Stock Connect Internet ETF, and HK Stock Connect Innovative Drug ETF have all received net inflows, highlighting the market's preference for Hong Kong stock assets and reflecting the current structural allocation logic in the market. (Securities Daily)

### Related Stocks

- [520570.CN - China Southern Hang Seng TECH ETF(QDII)](https://longbridge.com/en/quote/520570.CN.md)
- [520920.CN - Tianhong Hang Seng TECH ETF(QDII)](https://longbridge.com/en/quote/520920.CN.md)
- [159742.CN - Hang Seng TECH ETF I](https://longbridge.com/en/quote/159742.CN.md)
- [00HSI.HK - Hang Seng Index](https://longbridge.com/en/quote/00HSI.HK.md)
- [513180.CN - ChinaAMC Hang Seng Technology ETF(QDII)](https://longbridge.com/en/quote/513180.CN.md)
- [03033.HK - CSOP HS TECH](https://longbridge.com/en/quote/03033.HK.md)
- [159316.CN - E Fund Hang Seng SCHK Innovative Drug ETF](https://longbridge.com/en/quote/159316.CN.md)
- [513040.CN - E Fund CSI HK Connect Internet ETF](https://longbridge.com/en/quote/513040.CN.md)
- [159570.CN - China Universal CNI HK Connect Innovative Drugs Industry ETF](https://longbridge.com/en/quote/159570.CN.md)
- [159740.CN - Dacheng Hang Seng Technology ETF(QDII)](https://longbridge.com/en/quote/159740.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 由于春节赠品大战推动用户增长，人工智能应用在中国迅速崛起 | 中国科技巨头在春节促销活动期间报告了其人工智能应用的显著用户增长。阿里巴巴的 Qwen 应用记录了近 2 亿个订单，超过 400 万名 60 岁及以上的用户参与了该聊天机器人。美团的小团 AI 助手被超过 1 亿人用于假期规划。腾讯的元宝应 | [Link](https://longbridge.com/en/news/276715596.md) |
| 香港法院驳回了在具有里程碑意义的 “香港 47” 颠覆案中的上诉 | 香港上诉法院驳回了 12 名支持民主活动家的上诉，此案涉及一起与颠覆阴谋相关的重要国家安全案件。该案件被称为 “香港 47”，涉及在 2021 年初对主要支持民主人士的大规模逮捕，导致大多数人被判刑 4 至 10 年，仅有两人被宣判无罪。批 | [Link](https://longbridge.com/en/news/276558607.md) |
| 诺和诺德 UBT251 在华二期临床数据亮眼，减重效果近 20% | 诺和诺德授权药 UBT251 中国二期临床数据亮眼：用药 24 周体重最高减 19.7%（安慰剂仅 2%），公司称 “非常受鼓舞”。但受 Cagrisema 负面消息拖累，股价仍跌超 4%。诺和诺德已支付 2 亿美元首付款，总交易或达 20 | [Link](https://longbridge.com/en/news/276728466.md) |
| 中国医药系统的特应性皮炎药物获得中国批准 | 中国医疗系统获得特应性皮炎药物的中国批准 | [Link](https://longbridge.com/en/news/276718382.md) |
| 德琪医药与君实生物就 ATG-037 和 JS207 的组合达成临床合作 | 安腾生物科技有限公司已与上海君实生物达成临床合作，评估口服 CD73 抑制剂 ATG-037 与君实的 PD-1/VEGF 双特异性抗体 JS207 在中国大陆实体肿瘤患者中的联合应用。此次合作旨在探索不同肿瘤类型之间的潜在协同作用，并识别 | [Link](https://longbridge.com/en/news/276806135.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.